Anti-obesity combo may prevent diabetes in obese patients

tim_garveyThe investigational anti-obesity compound known as controlled-release (CR) phentermine/topiramate may prevent progression to type 2 diabetes in obese patients who are prediabetic, said W. Timothy Garvey, M.D.,  chair of the UAB Department of Nutrition Sciences. More of his study can be read on Renal & Urology News.